跳至主要内容
临床试验/NL-OMON50303
NL-OMON50303招募中不适用

Resistant HYpertension: MEasure to ReaCh Targets - RHYME-RCT

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 392 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
392

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Resistant hypertension: office blood pressure > 140 AND/OR 90 mmHg and 24h
  • ABPM (ambulatory blood pressure measurement) daytime blood pressure >135 AND/OR
  • 85 mmHg despite a medication regimen of antihypertensive drugs from at least
  • three classes including a diuretic or the use of at least four antihypertensive
  • drugs from different classes
  • * Secondary forms of hypertension have been excluded according to local
  • guidelines or a secondary form of hypertension has been established or is
  • likely but chosen treatment is drug therapy (for instance primary
  • hyperaldosteronism, renovascular hypertension)
  • * Use of at least two drugs for which DBS-analysis is available (angiotensin
  • converting enzyme inhibitors: enalapril and perindopril; angiotensin II
  • receptor blockers: candesartan, irbesartan, losartan, telmisartan, valsartan;
  • diuretics: bumetanide, chlorthalidone, hydrochlorothiazide and spironolactone;
  • calcium channel blockers: amlodipine, barnidipine, lercanidipine, and
  • nifedipine; beta blocker: metoprolol; alpha blocker: doxazosine).
  • * Age * 18 years
  • * Providing informed consent after reading patient information

排除标准

  • * Not providing informed consent or not capable of giving informed consent
  • * End-stage renal disease (eGFR<15 ml/min)
  • * Insufficient understanding of Dutch or Turkish language

研究者

相似试验